Observational study of the usefulness of an iron metabolism-related molecule hepcidin as a therapeutic response biomarker in Mycobacterium tuberculosis patients.
Not Applicable
Recruiting
- Conditions
- Mycobacterium tuberculosis infection
- Registration Number
- JPRN-UMIN000016454
- Lead Sponsor
- Graduate School of Medicine, Yokohama City University, Department of Respirology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Individuals without capability of informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relation between period required for improvement in clinical symptoms or bacteriological examinations and hepcidin level.
- Secondary Outcome Measures
Name Time Method